{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:37:17Z","timestamp":1790120237536,"version":"4.0.1"},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["16 0653"],"award-info":[{"award-number":["16 0653"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005390","name":"Alfred \u00d6sterlunds Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kocks stiftelser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196598","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T17:36:29Z","timestamp":1525887389000},"page":"e0196598","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse"],"prefix":"10.1371","volume":"13","author":[{"given":"Sahar","family":"Tahvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"T\u00f6rngren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Leanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2517-6646","authenticated-orcid":true,"given":"Fredrik","family":"Ivars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"A Katsarou","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","article-title":"Harnessing the power of regulatory T cells to control autoimmune diabetes: overview and perspective","author":"H Yu","year":"2017","journal-title":"Immunology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","article-title":"The NOD mouse: a model of immune dysregulation","volume":"23","author":"MS Anderson","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"ref4","first-page":"1","article-title":"Breeding of a non-obese, diabetic strain of mice","volume":"29","author":"S Makino","year":"1980","journal-title":"Jikken Dobutsu"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0065-2776(04)84007-0","article-title":"The pathogenesis of diabetes in the NOD mouse","volume":"84","author":"M Solomon","year":"2004","journal-title":"Adv Immunol"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"e0144090","DOI":"10.1371\/journal.pone.0144090","article-title":"E2-2 Dependent Plasmacytoid Dendritic Cells Control Autoimmune Diabetes","volume":"10","author":"L Hansen","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.43.5.667","article-title":"Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice","volume":"43","author":"A Jansen","year":"1994","journal-title":"Diabetes"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/diab.37.7.989","article-title":"Evidence for initial involvement of macrophage in development of insulitis in NOD mice","volume":"37","author":"KU Lee","year":"1988","journal-title":"Diabetes"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/labinvest.3780080","article-title":"Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice","volume":"80","author":"JG Rosmalen","year":"2000","journal-title":"Lab Invest"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nri2787","article-title":"Immune cell crosstalk in type 1 diabetes","volume":"10","author":"A Lehuen","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1900\/RDS.2009.6.97","article-title":"Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations","volume":"6","author":"JM Phillips","year":"2009","journal-title":"Rev Diabet Stud"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.166.4.823","article-title":"Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells","volume":"166","author":"A Bendelac","year":"1987","journal-title":"J Exp Med"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/diab.45.10.1299","article-title":"Diabetogenic T-cell clones","volume":"45","author":"K Haskins","year":"1996","journal-title":"Diabetes"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1084\/jem.183.1.67","article-title":"CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells","volume":"183","author":"FS Wong","year":"1996","journal-title":"J Exp Med"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1034\/j.1399-0039.2003.00152.x","article-title":"A comprehensive guide to antibody and T-cell responses in type 1 diabetes","volume":"62","author":"SM Lieberman","year":"2003","journal-title":"Tissue Antigens"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.09.012","article-title":"A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes","volume":"41","author":"ST Ferris","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1084\/jem.20011353","article-title":"Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice","volume":"196","author":"MC Gagnerault","year":"2002","journal-title":"J Exp Med"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.189.2.331","article-title":"Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes","volume":"189","author":"P Hoglund","year":"1999","journal-title":"J Exp Med"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.20030966","article-title":"Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model","volume":"198","author":"S Turley","year":"2003","journal-title":"J Exp Med"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.179.8.5041","article-title":"The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse","volume":"179","author":"V Saxena","year":"2007","journal-title":"J Immunol"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2337\/diabetes.49.7.1106","article-title":"Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice","volume":"49","author":"DG Alleva","year":"2000","journal-title":"Diabetes"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4049\/jimmunol.168.1.188","article-title":"Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function","volume":"168","author":"B Poligone","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nm.3042","article-title":"Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes","volume":"19","author":"J Diana","year":"2013","journal-title":"Nat Med"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.4049\/jimmunol.0804358","article-title":"Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice","volume":"184","author":"H Brauner","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ni.1834","article-title":"The activating receptor NKp46 is essential for the development of type 1 diabetes","volume":"11","author":"C Gur","year":"2010","journal-title":"Nat Immunol"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/intimm\/9.8.1159","article-title":"Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice","volume":"9","author":"T Akashi","year":"1997","journal-title":"Int Immunol"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1084\/jem.184.5.2049","article-title":"B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new &quot;speed congenic&quot; stock of NOD.Ig mu null mice","volume":"184","author":"DV Serreze","year":"1996","journal-title":"J Exp Med"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1586\/eci.10.68","article-title":"An update on the use of NOD mice to study autoimmune (Type 1) diabetes","volume":"6","author":"RJ Chaparro","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrendo.2014.236","article-title":"Thinking bedside at the bench: the NOD mouse model of T1DM","volume":"11","author":"JC Reed","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2005.08.002","article-title":"A comprehensive review of interventions in the NOD mouse and implications for translation","volume":"23","author":"LK Shoda","year":"2005","journal-title":"Immunity"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1073\/pnas.91.1.123","article-title":"Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice","volume":"91","author":"L Chatenoud","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.4049\/jimmunol.143.5.1555","article-title":"Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes","volume":"143","author":"AR Hayward","year":"1989","journal-title":"J Immunol"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diab.41.3.385","article-title":"Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody","volume":"41","author":"KC Herold","year":"1992","journal-title":"Diabetes"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1172\/JCI32405","article-title":"Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice","volume":"117","author":"CY Hu","year":"2007","journal-title":"J Clin Invest"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.4049\/jimmunol.180.5.2863","article-title":"B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions","volume":"180","author":"Y Xiu","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrendo.2012.237","article-title":"Immune therapy in type 1 diabetes mellitus","volume":"9","author":"A Lernmark","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/cei.12085","article-title":"Progress in immune-based therapies for type 1 diabetes","volume":"172","author":"M von Herrath","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1567-5769(01)00041-8","article-title":"Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system","volume":"1","author":"G Hedlund","year":"2001","journal-title":"Int Immunopharmacol"},{"issue":"1\u20132","key":"ref39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(02)00225-4","article-title":"The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis","volume":"130","author":"C Brunmark","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"ref40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.02.016","article-title":"Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1\/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats","volume":"156","author":"JS Yang","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/art.33493","article-title":"Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus","volume":"64","author":"AA Bengtsson","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.intimp.2013.12.008","article-title":"The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: leukocyte- and context-specific effects","volume":"18","author":"A Deronic","year":"2014","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ajpath.2013.01.032","article-title":"Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells","volume":"182","author":"S Helmersson","year":"2013","journal-title":"Am J Pathol"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2013.02.023","article-title":"Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice","volume":"228","author":"L Yan","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11912-013-0295-7","article-title":"Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer","volume":"15","author":"S George","year":"2013","journal-title":"Curr Oncol Rep"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1517\/13543784.2010.514262","article-title":"The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer","volume":"19","author":"JT Isaacs","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pbio.1000097","article-title":"Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides","volume":"7","author":"P Bjork","year":"2009","journal-title":"PLoS Biol"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","article-title":"The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer","volume":"86","author":"JM Ehrchen","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"1\u20132","key":"ref49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cccn.2004.02.023","article-title":"Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation","volume":"344","author":"D Foell","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00726-010-0528-0","article-title":"Inflammation-associated S100 proteins: new mechanisms that regulate function","volume":"41","author":"J Goyette","year":"2011","journal-title":"Amino Acids"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"e45478","DOI":"10.1371\/journal.pone.0045478","article-title":"An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis","volume":"7","author":"A Cesaro","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2567.2012.03619.x","article-title":"Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent","volume":"137","author":"M Riva","year":"2012","journal-title":"Immunology"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/art.33495","article-title":"Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4","volume":"64","author":"RF Schelbergen","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12885-016-2649-7","article-title":"Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth","volume":"16","author":"A Deronic","year":"2016","journal-title":"BMC Cancer"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.intimp.2010.04.011","article-title":"Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757","volume":"10","author":"M Stenstrom","year":"2010","journal-title":"Int Immunopharmacol"},{"issue":"Pt 4","key":"ref56","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/brain\/awt023","article-title":"Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis","volume":"136","author":"V Jolivel","year":"2013","journal-title":"Brain"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"e33797","DOI":"10.1371\/journal.pone.0033797","article-title":"Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity","volume":"7","author":"U Schulze-Topphoff","year":"2012","journal-title":"PLoS One"},{"issue":"1\u20132","key":"ref58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2010.07.009","article-title":"Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis","volume":"227","author":"C Wegner","year":"2010","journal-title":"J Neuroimmunol"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0028-3908(02)00015-1","article-title":"Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1\/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue","volume":"42","author":"LP Zou","year":"2002","journal-title":"Neuropharmacology"},{"issue":"416","key":"ref60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7543","article-title":"PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes","volume":"9","author":"M Ben Nasr","year":"2017","journal-title":"Sci Transl Med"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s40618-017-0641-y","article-title":"Immunotherapy for type 1 diabetes","volume":"40","author":"D Frumento","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trsl.2010.05.004","article-title":"The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats","volume":"156","author":"M Kamper","year":"2010","journal-title":"Transl Res"},{"issue":"42","key":"ref63","doi-asserted-by":"crossref","first-page":"16242","DOI":"10.1073\/pnas.0808031105","article-title":"Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice","volume":"105","author":"M Koulmanda","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.2337\/diabetes.53.7.1700","article-title":"Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4","volume":"53","author":"N Ogawa","year":"2004","journal-title":"Diabetes"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diabetes.51.3.638","article-title":"Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice","volume":"51","author":"A Rabinovitch","year":"2002","journal-title":"Diabetes"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3727\/096368910X557263","article-title":"Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces beta-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice","volume":"20","author":"WL Suarez-Pinzon","year":"2011","journal-title":"Cell Transplant"},{"issue":"9","key":"ref67","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1172\/JCI32959","article-title":"Recovery from diabetes in mice by beta cell regeneration","volume":"117","author":"T Nir","year":"2007","journal-title":"J Clin Invest"},{"issue":"7","key":"ref68","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nbt1115","article-title":"New sources of pancreatic beta-cells","volume":"23","author":"S Bonner-Weir","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"11","key":"ref69","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ncb1104-1021","article-title":"Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine","volume":"6","author":"PA Halban","year":"2004","journal-title":"Nat Cell Biol"},{"issue":"4","key":"ref70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/labinvest.3700238","article-title":"Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study","volume":"85","author":"T Nikolic","year":"2005","journal-title":"Lab Invest"},{"issue":"6","key":"ref71","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2353\/ajpath.2006.060539","article-title":"In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model","volume":"169","author":"B Calderon","year":"2006","journal-title":"Am J Pathol"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4049\/jimmunol.159.1.401","article-title":"Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1","volume":"159","author":"IS Grewal","year":"1997","journal-title":"J Immunol"},{"issue":"11","key":"ref73","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2337\/db08-0625","article-title":"Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes","volume":"57","author":"AP Martin","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.20111009","article-title":"Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis","volume":"209","author":"F Leuschner","year":"2012","journal-title":"J Exp Med"},{"issue":"2","key":"ref75","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajpath.2012.05.011","article-title":"Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod","volume":"181","author":"MK Mishra","year":"2012","journal-title":"Am J Pathol"},{"issue":"5","key":"ref76","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1189\/jlb.68.5.621","article-title":"Linomide abolishes leukocyte adhesion and extravascular recruitment induced by tumor necrosis factor alpha in vivo","volume":"68","author":"XW Zhang","year":"2000","journal-title":"J Leukoc Biol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1038\/ncomms7915","article-title":"Extracellular MRP8\/14 is a regulator of beta2 integrin-dependent neutrophil slow rolling and adhesion","volume":"6","author":"M Pruenster","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"e59701","DOI":"10.1371\/journal.pone.0059701","article-title":"Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse","volume":"8","author":"JA Carrero","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/cyto.2002.1956","article-title":"Cytokine production in Linomide-treated nod mice and the potential role of a Th (1)\/Th(2) shift on autoimmune and anti-inflammatory processes","volume":"19","author":"L Weiss","year":"2002","journal-title":"Cytokine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T14:38:48Z","timestamp":1693665528000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196598"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Fiorina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":79,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196598","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]}}}